Skip to main content
Clinical Trials/NCT05493384
NCT05493384
Unknown
N/A

Telerehabilitation in Rheumatic Diseases During the Process of COVID-19 Pandemic

Gazi University1 site in 1 country30 target enrollmentJuly 25, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Telerehabilitation
Sponsor
Gazi University
Enrollment
30
Locations
1
Primary Endpoint
Hospital Anxiety and Depression Scale
Last Updated
3 years ago

Overview

Brief Summary

Telerehabilitation (TR) became more popular during COVID-19 pandemic due to social isolation and curfew. Exercise is one of treatments for patients with rheumatic diseases that are known to have low levels of physical activity.

Detailed Description

Telerehabilitation (TR) aims to decrease barriers such as distance, time and cost by using technology to patients and clinicians. It provides to obtain rehabilitation for patients who cannot go to a medical center due to physical, environmental or economic inadequacies. COVID-19 is a contagious respiratory disease that is caused Severe Acute Respiratory Syndrome causing Coronavirus-2 (SARS-CoV-2). It was firstly seen in December 2019 in Wuhan, China and spread rapidly all over the world. World Health Organization (WHO) was declared COVID-19 as a pandemic in March 2020. The most common symptoms are fever, cough and dyspnoea. Social isolation and staying home have been suggested to reduce the spreading rate of COVID-19 pandemic in many countries. In addition, curfew except necessity was applied in some countries and time of curfew varied by country. Patients with rheumatic diseases are at higher risk of infections because of disease activity and immunosuppression. In addition, old age and having concomitant chronic disease are among risk factors for coronavirus. Therefore, national health services recommend patients to practice self-isolation and self-quarantine. However, social isolation was concluded with more increased physical inactivity and sedentary lifestyle. Physical inactivity and disuse are proven to cause joint destruction, decreased aerobic capacity and muscle atrophy in patients with rheumatic diseases.The importance and requirement for TR were observed better during the COVID-19 pandemic. Therefore, aim of this study was to investigate the effects of TR on fatigue, depression, anxiety, sleep quality, disease activity and quality of life.

Registry
clinicaltrials.gov
Start Date
July 25, 2022
End Date
November 20, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Songul Baglan Yentur

Assistant professor

Gazi University

Eligibility Criteria

Inclusion Criteria

  • Between the ages of 18 to 65
  • Have diagnosed with Romatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erthematosus or Fibromyalgia

Exclusion Criteria

  • Being pregnant
  • Diagnosed with malignancy
  • Had changes of medical treatment in the last 3 months
  • Had dysfunction that limited physical activity such as severe neurological impairment, immobility or cooperation deficits
  • Had regular exercise habit (minimally three days in a week)
  • Had cardiac symphtoms according to New York Heart Association

Outcomes

Primary Outcomes

Hospital Anxiety and Depression Scale

Time Frame: 2 minutes

It consists of 14 questions that which 7 of them evaluate depression and 7 of them evaluate anxiety. Each question is scored from 0 to 3 and high scores indicate severe anxiety and depression

Fatigue severity scale

Time Frame: 2 minutes

Fatigue is a normal response to physical exertion or stress but can also be a sign of a physical disorder. In the common sense, fatigue is a condition known to everyone from his or her own experience,irrespective of his or her age, gender, or health. Fatigue severity scale consists of nine questions; each question is scored from 1 to 7

Secondary Outcomes

  • Health Assessment Questionnaire(2 minutes)
  • Pittsburg Sleep Quality Index(3 minutes)

Study Sites (1)

Loading locations...

Similar Trials